F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
Based on interview and record review the facility failed to prevent medication errors, which included the
dispensing and administration of discontinued medications and the incorrect administration of an antibiotic.
This affected three residents (Residents #218, #229, and #274) of five residents sampled for medication
errors. The facility census was 74.
Residents Affected - Some
1. Review of the physician orders dated 08/17/21 for the Former Specified Resident (FSR) #274, revealed
an order for Tramadol tablet, 50 mg (milligrams), four times a day. The physician order for Tramadol, a
scheduled IV medication, was discontinued on 08/19/22.
Review of the medication error report form dated 08/23/22 revealed the medication was administered in
error to FSR #274 on 08/20/22, 08/21/22, and 08/22/22 by specified perpetrator (SP) #391.
Review of progress notes for FSR #274 dated 08/24/23 at 8:30 A.M. revealed the family and physician were
notified, head to toe assessment was completed, and no new orders were implemented.
Review of the controlled narcotic record dated 08/13/22 to 08/22/22, for FSR #274, revealed no
discrepancies related to the allegation.
Review of the personnel file for Licensed Practical Nurse (LPN) #391 dated 08/31/22, revealed the LPN
#391 received education and coaching on the five rights of medication administration.
2. Review of the physician orders dated 03/09/23 for Resident #229, revealed an order for Erythromycin
500 mg tablet, three times a day.
Review of the medication error investigation dated 03/09/23 revealed the medication Erythromycin was not
administered per the physician order and Azithromycin tablet, 500 mg, was administered once in error to
Resident #229 on 03/09/23 LPN #391.
Review of progress notes on 03/10/23 for Resident #229, revealed the family and physician were notified,
head to toe assessment was completed, and no new orders were implemented.
Review of the personnel file for LPN #391 dated 03/17/23, revealed LPN #391 received additional
education and coaching on the five rights of medication administration.
Interview on 04/17/23 at 10:42 A.M. with Resident #241, revealed no concerns related to medication
administration.
3. Review of the physician orders dated 12/15/22 for Resident #218, revealed an order for Xanax,
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
365268
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365268
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/20/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Altercare of Wadsworth
147 Garfield St
Wadsworth, OH 44281
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Minimal harm
or potential for actual harm
0.5 mg, twice a day as needed for anxiety. The physician order for Xanax, a scheduled IV medication, was
discontinued on 03/01/23.
Review of the medication error investigation dated 03/29/23 revealed the medication was administered in
error to Resident #218 on 08/20/22, 08/21/22, and 08/22/22 by LPN #391.
Residents Affected - Some
Review of progress notes on 03/29/23 of the Resident #218, revealed the family and physician were
notified, head to toe assessment was completed, and no new orders were implemented.
Review of the controlled narcotic record dated 02/24/23 to 03/09/23, of Resident #218 revealed no
discrepancies related to the allegation.
Review of the personnel file for LPN #391 dated 03/20/23, revealed LPN #391 was disciplined for work
absences. LPN #391 left the building and did not return to the facility.
Interview on 04/17/23 at 2:55 P.M. of the Director of Nursing (DON), revealed she confirmed the medication
administration errors. The DON further revealed on 03/20/23 after a disciplinary action, LPN #391 did not
return to the facility.
This deficiency represents non-compliance investigated under Complaint Number OH00139439.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365268
If continuation sheet
Page 2 of 2